Sugi Predict

Sugi Predict / Compounds / SCHEMBL21591766

SCHEMBL21591766

SCHEMBL21591766

O=S(=O)(CCNc1cc(-c2c[nH]c3nccc(Oc4ccc5c(c4)CNCC5)c23)ncn1)c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CLK4 Q9HAZ1 8/20 0.37
▸ CDK2 P24941 5/20 0.37
▸ CDC7 O00311 4/20 0.37
▸ ROCK2 O75116 4/20 0.37
▸ PIM1 P11309 4/20 0.37
▸ PRKACA P17612 4/20 0.37
▸ GSK3B P49841 4/20 0.37
▸ HIPK2 Q9H2X6 4/20 0.37
▸ IRAK4 Q9NWZ3 4/20 0.37
▸ PLK4 O00444 1/20 0.37
▸ CHEK1 O14757 1/20 0.37
▸ JAK2 O60674 1/20 0.37
▸ EGFR P00533 1/20 0.37
▸ INSR P06213 1/20 0.37
▸ CSF1R P07333 1/20 0.37
▸ RET P07949 1/20 0.37
▸ MET P08581 1/20 0.37
▸ KIT P10721 1/20 0.37
▸ FGFR1 P11362 1/20 0.37
▸ TYK2 P29597 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29836334 1.00 CLK4 (0.37) CLK4CDK2CDC7ROCK2PIM1
SCHEMBL29836410 0.88 CLK4 (0.41) CLK4CDK2CDC7ROCK2PIM1
SCHEMBL21591756 0.88 CLK4 (0.41) CLK4CDK2CDC7ROCK2PIM1
SCHEMBL21591781 0.86 CLK4 (0.50) CLK4CDK2CDC7ROCK2PIM1
SCHEMBL29836408 0.86 CLK4 (0.50) CLK4CDK2CDC7ROCK2PIM1
SCHEMBL21591786 0.85 CYP1A2 (0.38) CLK4CDK2CDC7ROCK2PIM1
SCHEMBL29836544 0.85 CYP1A2 (0.38) CLK4CDK2CDC7ROCK2PIM1
SCHEMBL21591784 0.82 ADORA3 (0.40) CLK4CDC7GSK3BEGFRMET
SCHEMBL29836321 0.82 ADORA3 (0.40) CLK4CDC7GSK3BEGFRMET
SCHEMBL21593241 0.82 ACACB (0.36) CLK4CDK2CDC7ROCK2PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3807273-B1 AZAINDOLE DERIVATIVES AS RHO-KINASE INHIBITORS CHIESI FARM SPA (IT) 2022-08-03 — — EP claimed
US-20210253568-A1 AZAINDOLE DERIVATIVES AS RHO-KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2021-08-19 — — US claimed
EP-3807273-A1 AZAINDOLE DERIVATIVES AS RHO- KINASE INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2021-04-21 — — EP claimed
WO-2019238628-A1 AZAINDOLE DERIVATIVES AS RHO- KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2019-12-19 — — WO claimed
EP-3807273-B1 AZAINDOLE DERIVATIVES AS RHO-KINASE INHIBITORS CHIESI FARM SPA (IT) 2022-08-03 — — EP disclosed
US-20210253568-A1 AZAINDOLE DERIVATIVES AS RHO-KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2021-08-19 — — US disclosed
US-20210253568-A1 AZAINDOLE DERIVATIVES AS RHO-KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2021-08-19 — — US disclosed
WO-2019238628-A1 AZAINDOLE DERIVATIVES AS RHO- KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2019-12-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210253568-A1 AZAINDOLE DERIVATIVES AS RHO-KINASE INHIBITORS ROCK1, ROCK2, RHOA CLK4 4157/4885CDK2 730/4885CDC7 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.